Sanoosa‑002
Solid Tumor Oncology
PreclinicalActive
Key Facts
About Sanoosa
Australian biotech developing oral small‑molecule drugs for inflammation, oncology and viral infections.
View full company profileTherapeutic Areas
Other Solid Tumor Oncology Drugs
| Drug | Company | Phase |
|---|---|---|
| CIK Cell Immunotherapy | Cytopeutics | Phase 1 |
| TJC0434 | TaiwanJ Pharmaceuticals | Preclinical |